Free practice quiz
CMTMS Prep Course (CMTMS): free quiz
10 questions from the program. See your score right away, then unlock the explanation of every answer.
- Question 1 of 10
A mass tort intake file contains pharmacy records showing Product X dispensed on 03/02/2022 and a later specialist note stating the claimant’s condition is “possibly related” to Product X. The program criteria require documented exposure, documented injury, and supervisory review for causation questions. What is the reviewer’s most appropriate action?
Option A is correct because the support role is to capture documented facts, apply stated workflow rules, and escalate reserved causation issues. Option A overreaches by treating incomplete criteria as final eligibility. Option C gives legal advice and converts a medical note into a legal conclusion. Option D also overreaches by making a final exclusion rather than following the stated escalation trigger. Reviewers should distinguish objective evidence from inference and preserve defensible documentation for attorney, clinician, or program-lead review.
- Question 2 of 10
During CMTMS intake, a claimant file includes a pharmacy printout showing ranitidine 150 mg by mouth twice daily, filled monthly from March through June 2018. The intake form alleges bladder cancer, but the file contains no pathology report, oncology note, or diagnosis code. The program rule requires documented qualifying product use and documented qualifying diagnosis before attorney review. What is the best next action?
D is correct. The task is screening, not final eligibility or causation. The objective fact is documented ranitidine use; the alleged diagnosis remains unsupported. Applying the rule requires both elements, so the reviewer should document what is proven and request or escalate missing records. A is tempting because exposure is documented, but an intake allegation is not diagnosis proof. C exceeds role scope by deciding causation. B is premature unless the governing workflow says missing initial records require closure rather than cure or escalation.
- Question 3 of 10
A case intake specialist opens a new fictional mass tort file. The caller states she received Product X in 2019, had revision surgery in 2022, and has only a discharge summary available. Which intake entry best captures core data elements without exceeding the reviewer role?
Core intake should capture standardized identity, contact, demographics, case identifiers, products or exposures, alleged injuries, key dates, source, and record status. Option B preserves documented and reported facts while flagging missing records. A overstates causation and eligibility. A omits relevant reported exposure data instead of labeling its source. A delays intake and undermines downstream tracking; incomplete files should be opened with clear status fields.
- Question 4 of 10
A settlement program states that a claimant meets the product-use threshold only with a dated operative report, implant log, or manufacturer invoice showing Device X implanted from 2014–2018. Supporting evidence may include questionnaires or symptom notes. The file has a questionnaire stating “I think Device X was used,” a 2016 knee operative report listing no brand, and a 2020 revision report. What is the best pre-screen action?
D is correct: the written threshold requires specified source documentation; supporting evidence cannot replace it. A is tempting because the revision timing is relevant, but timing does not prove product use. C is tempting because claimant statements help intake, but the rule limits threshold proof to operative, implant, or invoice records. B is improper because reviewers must not infer eligibility or override criteria. Document the gap objectively and follow the request/escalation workflow.
- Question 5 of 10
During intake for a mass tort file, the claimant reports using Product X from March to June 2021 and having headaches. Records received include a pharmacy receipt for Product X dated 2021-04-12 and an urgent care note dated 2021-05-03 stating “headache reported.” Which summary sentence is most appropriate for a neutral intake summary?
Option A is correct because it separates claimant report from record evidence, uses consistent dates, and avoids causation, diagnosis, or eligibility conclusions. Option C is tempting because exposure and symptoms appear close in time, but it makes an unsupported causation conclusion. Option B is tempting because records exist, but it states eligibility, which is reserved for program criteria or supervisory review. Option D is tempting because the urgent care note mentions headache, but “reported headache” is not the same as a diagnosed Product X-related condition.
- Question 6 of 10
During mass tort intake, a claimant reports that a device-related infection was first identified after surgery. The file contains an office visit note, a hospital discharge summary, a radiology report, and an operative report. Which record category is usually the best source to establish the procedure date and what was done during the procedure?
Operative reports are the strongest category for the exact procedure performed, operative findings, implants or removals noted, and procedure timing. Office notes may show symptoms or follow-up but are secondary for operative details. Discharge summaries are useful for admission course and diagnoses, but they summarize rather than replace source procedure documentation. Radiology reports establish imaging findings and timing of imaging, not what occurred in surgery. When records conflict, reviewers should prefer the most direct source document for the fact being abstracted and flag unresolved discrepancies rather than infer missing facts.
- Question 7 of 10
As a mass tort medical and claims support reviewer, you are building a chronology from records. A pharmacy profile lists sertraline 50 mg by mouth once daily, filled 2021-04-03. A clinic note says the claimant reported rash symptoms “in early April 2021,” and a dermatology note documents diagnosis on 2021-04-19. Which timeline entry best follows chronology construction principles?
Option C is correct because it uses a standardized date format, separates medication exposure, symptom report, and diagnosis, anchors each event to a source, and preserves uncertainty for “early April.” Option A is tempting because it uses the fill date, but it converts exposure into causation. Option D is tempting as a summary, but it collapses distinct milestones and weakens auditability. Option B is tempting because it creates a clean sequence, but it invents an exact onset date, causation, and eligibility determination outside the reviewer’s role.
- Question 8 of 10
During a mass tort intake review, the claimant questionnaire alleges a device-related injury in March 2022. The file contains billing summaries, a signed authorization, and pharmacy records, but no operative report, imaging report, pathology report, or clinician diagnosis confirming the alleged injury. Program screening requires documented exposure and diagnostic proof before escalation. What is the best gap documentation entry?
Choice D is correct because it identifies the threshold-critical missing item, states the unresolved issue, and links the request to specific record types. Choice C is too generic and may not guide retrieval. Choice B improperly treats claimant statements and billing summaries as diagnostic proof when the program requires documentation. Choice D misclassifies the issue; a valid authorization helps obtain records but does not substitute for proof of diagnosis.
- Question 9 of 10
During mass tort record abstraction, a hospital operative note lists “left nephrectomy” in the procedure history. To code the chronology accurately, which interpretation should the reviewer enter?
D is correct. “Nephr/o” refers to kidney, and “-ectomy” means surgical removal, so “left nephrectomy” documents removal of the left kidney. A is tempting because it uses the same root, but inflammation would be “nephritis” because “-itis” means inflammation. C confuses a procedure with imaging; imaging terms often use “-graphy” or “-gram.” B confuses pathology with size; enlargement is commonly indicated by “-megaly.” Accurate word-part interpretation supports objective abstraction without adding unsupported clinical conclusions.
- Question 10 of 10
During intake review, a claimant’s medication list includes lisinopril 10 mg by mouth once daily. The chart also contains a pulmonary function test, chest CT, and notes describing dyspnea and wheezing. As a CMTMS reviewer organizing records by body system, where should these materials primarily be indexed?
D is correct. Dyspnea, wheezing, pulmonary function testing, and chest CT primarily concern the lungs and airways, so the records should be organized under the respiratory system. C is tempting because lisinopril is cardiovascular, but the question asks where to index the described symptoms and tests. A is a dose-monitoring trap: renal monitoring may matter for some drugs, but no kidney test or renal complaint is presented. B confuses document location with medical classification. The reviewer should classify objective records without diagnosing causation.
See why each answer is right or wrong
Enter your email to unlock the explanation of every question, free.